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ABSTRACT

IDENTIFYING THE 5’END
OF THE CAMTA1 GENES IN ZEBRAFISH

Morgan Roberta Fronk
Department of Physiology and Developmental Biology
Bachelor of Science

Congenital heart diseases (CHDs) are a significant cause of infant death and are
frequently caused by mutations in transcription factors. Camta1 (calmodulin binding
transcription activator 1) is a transcription factor that has been proposed as a modulator in
embryonic heart development and a possible cause of CHDs. The only other known
member of its family in vertebrates is involved in activating a hypertrophy gene program
in adult heart failure. Unlike camta2, camta1 is expressed in the embryonic heart during
heart looping. However, few studies have been done on camta1. In zebrafish, there are
two camta1 ohnologs (homologs created through a duplication event), camta1a and
camta1b. These have not yet been annotated fully so the 5’end is unknown, preventing
further analysis and study. Here, we use 5’RLM-RACE (RNA Ligase Mediated Rapid
Amplification of cDNA Ends) to determine the 5’end of camta1a and begin the process
of understanding camta1 regulation through nucleotide BLAST. Future studies can build
on this and elucidate the regulation of the camta1 genes in zebrafish by locating the 5’end
of camta1b, determining the promoter regions of both genes, and beginning studies on its
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downstream targets, which may reveal an important role for camta1 in cardiac
development.
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I. Background and Significance
Congenital heart disease (CHD) is the most common birth defect in the United States,
affecting nearly 40,000 or 1% of live births annually (Hoffman and Kaplan, 2002). The
etiology of CHDs is not fully understood, although recent research is establishing the
significance of genetics in contributing to its incidence (Edwards and Gelb, 2016).
Determining the genes involved in embryonic heart development can contribute to
improved understanding of the gene mutations involved in CHDs and lead to better
methods for diagnosis, treatment, and prevention. However, identifying these genes alone
is not enough. It will also be necessary to understand the transcriptional regulation of
these genes, which controls how these genes are expressed. Heart formation requires
complex patterns of gene expression, requiring dynamic transcriptional regulation that is
not well understood (Nemer, 2007). Elucidating these regulatory pathways will not only
expand our knowledge of cardiac development but may also reveal links between these
transcriptional regulators and CHDs.
Due to the complexity of gene expression required for cardiac development, many
transcription factors are needed to regulate this process. Family-based heritability studies
on CHDs have primarily identified transcription factors, indicating that many of the
known causes of CHDs in humans are mutations in such factors (Reamon-Buettner and
Borlak, 2010). Transcription factors identified in early heart morphogenesis include
GATA4, Nkx2.5, Tbx5, Hand1, and Hand2. Mutations of these factors have been
associated with many types of CHDs in humans, although their exact molecular
mechanisms are not yet fully understood (Nemer, 2007). For example, Nkx2.5 mutations
in humans are known to cause cardiomyopathy, septal defects, and conduction defects
(Hanley et al., 2016; Xu et al., 2017a; Xu et al., 2017b), while the absence of the Nkx2.5
1

homologs, nkx2.5 and nkx2.7, in zebrafish results in abnormal ventricular and atrial
development (Targoff et al., 2009; Reamon-Buettner and Borlak, 2010). However, few of
the downstream targets of Nkx2.5 have been identified (Targoff et al., 2009) and its role
in the transcriptional regulatory network driving cardiac development is still being
defined (Yan et al., 2017). As the role of transcription factors in heart development is
elucidated, their causative role in CHDs will become clearer as well (Nemer, 2007).
The camta1 (calmodulin binding transcription activator) gene has been proposed as a
possible candidate for regulation of cardiac development and involvement in CHDs
(Schwartz and Schneider, 2006). Little research has been done on this gene, but the only
other member of its family in vertebrates, camta2, is known to activate a hypertrophy
gene program in adult heart failure in mice (Song et al., 2006) through the interaction of
its CG-1 domain with the homeodomain of Nkx2.5 to activate transcription of
hypertrophic genes (Schwartz and Schneider, 2006). The amino acid sequences of
Camta1 and Camta2 share many homologous regions, including the CG-1 domain (figure
1) (Long et al., 2014). Camta2 is expressed only in adults while camta1 is strongly

Figure 1. Schematic illustrating homologous regions in the amino acid sequences of
mouse CAMTA1 and CAMTA2. CG-1 = Nunclear localization sequence, TAD =
Transactivation domain, TIG = DNA-binding motif, ANK = Ankyrin repeat, IQ =
Calmodulin binding domain. (Long et al., 2014).

expressed in the embryonic mouse heart (Song et al., 2006). RNA-seq time course
experiments by Dr. Jonathon Hill have determined that camta1 is transiently expressed
during heart morphogenesis, peaking at approximately 48 hours post fertilization (hpf)
(figure 2) (Hill et al., 2017), which is when heart looping occurs in zebrafish (Bakkers,
2

Figure 2. Self-organizing map (SOM) of time course data showing relative expression levels
over time. RNA-seq time course analysis was performed on all the genes in the heart, which
were organized into clusters according to their temporal expression patterns. camta1a and
camta1b expression fit into the first quadrant (indicated by the red box) (Hill et al. 2017).

2011). The brief temporal expression of camta1 in the embryonic heart suggests that it
has a very specific duty during that time period, rather than a more general one.
Computational analysis data show that camta1 has a high number of interactions with
other molecules, suggesting its role as an important regulator (figure 3) (Hill et al., 2017).
Preliminary CRISPR knockouts of camta1 performed by the Hill lab in zebrafish show
heart defects (figure 4) (courtesy of Z. Taylor). Embryos injected with CRISPR sgRNAs
targeting camta1a show a dilated atrium, shrunken ventricle, and lack of proper heart
looping. This phenotype is significant because it is similar to the Nkx2.5 phenotype
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Figure 3. Graph of known and predicted gene regulatory interactions for cluster
A1. Size of the node indicates the number of interactions it has with other
genes. Camta1 (circled in red) has the largest node and thus the largest number
of interactions, marking it as a likely regulator (Hill et al. 2017).

A.

B.

Figure 4. A. 48 hpf embryo with a healthy heart. The ventricle and atrium are roughly equal in
size and heart looping can be seen. B. 48 hpf embryo with camta1a knocked out using
CRISPR/Cas9 technology. The heart has an enlarged atrium, shrunken ventricle, and a looping
defect (courtesy of Z. Taylor).
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(Targoff et al., 2008), and Nkx2.5 is a known partner of Camta2 (Song et al., 2006).
These data indicate that camta1 plays an important role in embryonic heart development,
making it a promising candidate for further research.
While humans have only one camta1 gene, there are two camta1 ohnologs (camta1a
and camta1b) in zebrafish due to a whole-genome duplication (WGD) event that occurred
in an ancestral species approximately 350 million years ago. These genes show identical
temporal expression patterns (figure 5), suggesting that each retains an important role.

Figure 5. Temporal expression patterns of
camta1a and camta1b. Normalized read counts
are shown from 30 to 72 hpf. Note the similar
pattern, peaking at approximately 48 hpf (Hill
et al. 2017).

Again, we see that peak expression occurs around 48 hpf, simultaneous with heart
looping in zebrafish (Bakkers, 2011). Regions conserved on the promoter regions of both
camta1a and camta1b can thus be assumed to have essential functions and can be
compared to human camta1 in future studies (Kleinjan et al., 2008).
Most Camta1 research has been conducted in the plant Arabidopsis thaliana, which
contains a large family of orthologs closely related to Camta1 in vertebrates. One study
recently revealed that A. thaliana uses Camta proteins to regulate specific gene responses
5

to different calcium levels. Calcium signaling is sensed by a Ca2+-calmodulin-CAMTA
complex to code for specific gene expression responses in response to stress (Liu et al.,
2015). While this interaction has only been studied in plants so far, the calmodulinbinding IQ domain is conserved in vertebrates. The potential to respond to changing
calcium levels has significant implications for Camtas in heart development. Calcium
signaling has been shown to play an important role in cardiac development through
transcriptional regulation (Li et al., 2002; Linask et al., 2001), specifically during cardiac
looping (Porter et al., 2003). Other calmodulin-dependent enzymes have already been
implicated in cardiac hypertrophy and regulation of growth and function in response to
calcium in cardiomyocytes (Frey et al., 2000; Passier et al., 2000). We propose that
Camtas behave similarly to other calmodulin-dependent enzymes and their counterparts
in A. thaliana.
Taken together, this evidence suggests a model where camta1 translocates to the
nucleus and binds Nkx2.5 under specific circumstances to play an important role in the
activation of certain heart development genes. According to our model, stress causes
calcium signaling. This calcium signaling could be caused by voltage-gated calcium
channels, but it is more likely caused by developmental stressors like the build-up of
blood pressure in areas where certain structures of the heart, like the ventricle, need to
form. This stress-induced calcium signaling leads to the activation of calmodulin and
subsequent formation of Ca2+-calmodulin-Camta complexes. These complexes then
translocate to the nucleus (figure 6B). We hypothesize that this complex then interacts
with Nkx2.5 in the nucleus to activate transcription of genes necessary for ventricular
specification or maintenance(figure 6C). The full picture of how this plays out cannot be
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fully understood, however, without understanding what is occurring upstream of camta1
in its regulatory regions (figure 6A).
If camta1 is indeed an important regulator in heart development, it is essential to
understand how it is regulated itself. We hypothesize that the important regulatory

Figure 6. Model of camta1’s role in heart development. A. Regulation of camta1 B. Effects of
stress on calcium signaling and Camta1 C. Interaction of Ca2+-calmodulin-CAMTA with
Nkx2.5 in the nucleus (courtesy of J. Hill)

regions will be conserved between both ohnologs, as they have identical temporal
expression patterns. However, it is currently difficult to determine the regulation of
camta1 because its 5’ end is not fully annotated in zebrafish, so its promoter region and
transcription start site (TSS) are unknown, preventing bioinformatic comparison of the
regulation of both ohnologs. Defining the 5’ end and locating the TSS would enable
identification of the promoter, which would allow for further characterization and
annotation of camta1 (Kim et al., 2012). Recent bioinformatic analysis performed in the
Hill lab has indicated that the incomplete annotation may be due to exon one of both
camta1a and camta1b being located in the wrong place in the genomic annotation (figure
7

7, camta1a not pictured), but this cannot be confirmed until the zebrafish 5’UTR is
determined. Once the TSS has been identified, its genomic location can be determined
and homology analysis can be performed by aligning the putative promoter regions of
camta1a and camta1b to identify conserved regulatory elements in both ohnologs
(Kleinjan et al., 2008).

Figure 7. camta1b alignment compared to current annotation of zebrafish chromosome
11. This was determined by blasting a mouse exon one to the zebrafish genome but
cannot be confirmed until the zebrafish 5’UTR is determined. (courtesy of A. Martin).

To determine the camta1a and camta1b TSS, we used 5’RACE (Rapid Amplification
of cDNA Ends) using a primer set designed to both camta1a and camta1b. Amplification
of the 5’ end of camta1a was successful and confirmed that the annotation does have an
error in the genome assembly preventing proper annotation of the gene. Surprisingly, the
alignment of the identified 5’ end of zebrafish corresponded to exon 3 of mouse Camta1,
indicating that there is either an alternative TSS for camta1a in the heart, or that the 5’
end is not conserved between species. These results will be used to guide future
experiments to study the transcriptional regulation of camta1 in the developing zebrafish
heart.
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II. Materials and Methods
Primer design
Inner and outer primers were designed for both camta1a and camta1b using
Geneious primer design software and following the specifications given in the 5’RLMRACE protocol (Invitrogen). OligoAnalyzer 3.1 (Integrated DNA Technologies) was
used to check for self-dimers, heterodimers, hairpins, and GC content (Table 1). 5’RLMRACE uses a two-step PCR to increase specificity and thus requires two specific inner
and outer primers for each gene (figure 8). There is one primer for the initial PCR and
another for the second, embedded PCR.

Figure 8. 5’RACE inner and outer primers, included with the kit, bind to the 5’RACE
adapter, while specific inner and outer primers designed to bind to camta1a or b bind to
the gene. The 5’end to be amplified lies between these primers.

camta1a inner

CGTGGAGCATTTTGGTAGACAT

camta1a outer

TTCCACCTGTGTCTCTCCTTTG

camta1b inner

GCCTTAGATTGATTGGGAGGGT

camta1b outer

TTAGCAGGTGTCCTTGAGATGG

Table 1. Primers used for 5’RLM-RACE

Heart isolation
Zebrafish embryos (Danio rerio) with hearts expressing GFP were collected and
incubated for 48 hpf before being dechorionated. Hearts were then removed using a
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protocol modified from Burns and MacRae, 2006. Briefly, GFP-positive embryos were
fragmented with a 19-gauge needle in L-15 Leibowitz cell culture media enriched with
5% FBS. A pipet was used to separate the hearts underneath an Olympus SZX16
stereomicroscope based on green fluorescence. Extracted hearts were then placed in TRI
Reagent (Zymo), homogenized with an insulin needle, and stored at -80 °C until RNA
extraction.

RNA extraction
RNA was extracted from the isolated hearts with the Direct-zol RNA MicroPrep
kit (Zymo Research), following the included protocol. Due to the difficulty of extracting
only heart RNA and maintaining purity, RNA concentrations were low (40-50 ng/uL),
yielding less than 1 ug of RNA for the 5’RACE, enough for only a small reaction. The
5’RACE protocol recommended using 10 ug of RNA for a standard reaction, so we also
extracted RNA from whole zebrafish embryos using TRI Reagent (Zymo) and the Directzol RNA MicroPrep kit (Zymo Research) to obtain the needed amounts of material.
Concentrations were higher (ranging from 250-350 ng/uL), but only provided 4 ug.

5’RLM-RACE
Extracted RNA from hearts or whole embryos was used for 5’RLM-RACE with
the FirstChoice RLM-RACE kit (Invitrogen), following the included protocol. We
performed the small reaction, using up to 1 ug of RNA, several times and the standard
reaction, using approximately 4 ug of whole embryo RNA, once. A positive control from
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the kit was performed alongside these reactions, along with two non-template controls in
the PCR steps.

TOPO TA Cloning and Sequencing
The PCR product from the completed 5’RLM-RACE was cloned into bacteria
using the Zero Blunt TOPO PCR Cloning kit (Invitrogen). Bacteria was then spread on
LB plates containing Kanamycin and incubated at 37°C for 24 hours. Isolated colonies
were then chosen and transferred to 3 ml LB containing Kanamycin and incubated for an
additional 24 hours at 37°C. To prepare the bacteria for sequencing, DNA was extracted
using the GenElute Plasmid Miniprep kit (Sigma-Aldrich), following the included
protocol. The Big Dye sequencing reaction was then performed using standard methods
and read on an Applied Biosystems 3730xl DNA Analyzer at the BYU DNA Sequencing
Center.

Data Analysis
The 5’RACE insert was determined by using SnapGene to align sequencing
results against the PCR Blunt II TOPO vector. This insert was then aligned against the
zebrafish genome using NCBI Blast and analyzed and compared to mouse camta1 using
the Ensembl genome browser.
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III. Results
In order to locate the TSS on the camta1 genes in zebrafish, we conducted
5’RACE (Rapid Amplification of cDNA Ends). 5’RACE, also known as anchored PCR,
is used to amplify the 5’ ends of RNA strands when only a partial sequence is available.
We chose to use RNA Ligase Mediated RACE (RLM-RACE) because it improves on
classic RACE by preventing fragmented RNA from being amplified (figure 9). We

Figure 9. RLM-RACE protocol (provided
in Ambion RLM-RACE protocol).

performed both standard (10 ug of starting whole embryo RNA) and small reactions (<1
ug starting heart RNA) of the RACE, along with a positive control and non-template
controls. Samples were run on an agarose gel for visualization (figure 10). The standard
reaction (lanes 3-6) did not show any amplification, likely due to insufficient starting
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material (4 ug vs. 10 ug). However, the small reactions for camta1a (lanes 7 and 8)
yielded clear bands at approximately 80 bp. Neither the standard nor small camta1b
reactions (lanes 5, 6, 9, and 10) yielded visible bands. The positive controls (lanes 11 and
12) also did not amplify anything. This may be due to using rSAP (shrimp alkaline
phosphatase) instead of CIP (cow intestine phosphatase) on the first step of preparing the
positive control (see figure 9), as the kit ran out of CIP. Although we believed rSAP
should have the same effects as CIP, it may have affected the reaction by failing to
remove the 5’ phosphate group on fragmented mRNA or DNA, which might have been
amplified later. The non-template controls (lanes 13 and 14) showed nothing, as
expected.

1

2

3

4

5

6

7

8

9 10 11 12

13 14

Figure 10. Gel run to confirm 5’RACE results. Lane 1: 1 kb ladder 2: 100 bp ladder 3-4:
Standard A 5-6: Standard B 7-8: Small A 9-10: Small B 11-12: Positive control 13: NTC
with A primers 14: NTC with B primers
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The small camta1a samples were sequenced and the sequencing results were used
to determine the insert (figure 11), which was then aligned to the zebrafish genome. This
yielded a 100% match with a 61-base pair (bp) segment including bases 30,659,10930,659,169 on the forward strand of chromosome 23 in the GRCz11 Primary Assembly.
Interestingly, the current annotation of chromosome 23 (where camat1a is found) in
zebrafish places the insert on the reverse strand, running at 30,431,333-30,061,364 (see
figure 12). When compared to the mouse genome, our insert aligned to Camta1 exon 3
(data not shown).

*

Figure 11. Small A sequencing results compared against the PCR II Blunt TOPO vector to
determine the insert for BLASTing. The asterisk (*) marks sample F2, which was used to BLAST
against the zebrafish genome.

Figure 12. Comparison of the positioning of our insert in the current annotation and
chromosomal alignment of chromosome 23.

14

IV. Discussion and Conclusions
Here, we determined the location of the 5’end of camta1a through 5’RLM-RACE
and nucleotide BLAST. This is an important step for continuation of camta1 studies in
zebrafish in the future. Analysis of the 5’end of camta1a has already been very revealing,
suggesting several important steps for future studies.
The chromosomal alignment of our insert with the zebrafish genome supports our
prediction that the current annotation of camta1 in zebrafish is incorrect (see figures 7
and 10). Significantly, our insert falls near a contig boundary, where annotation mistakes
are more likely to occur. Once the 5’end of camta1b is located, it will be interesting to
see if it, too, is aligned differently than it appears in the current annotation.
Our insert also shows up in exon 3 of camta1 in the mouse genome, rather than at
the 5’end as expected. There are three main possibilities for this occurrence:
1. The insert we discovered is not the actual 5’end – This is unlikely as 5’RACE
(and especially 5’RLM-RACE) is generally highly accurate. The RLM-RACE
protocol incorporates a dephosphorylation step to prevent ligation of the 5’
primer to fragmented RNA or DNA. In addition, the BLAST alignment
extends across an exon boundary, suggesting that our results are not from
fragmented genomic DNA.
2. Evolutionary divergence between mice and zebrafish – Figure 1 shows that
the first functional domain of Camta1 begins at amino acid 63, and the
determined 5’ end is less than 100 bp from the annotated mouse ATG. Thus,
this insert could have been deleted in the zebrafish without affecting the
functionality of the protein. Evolutionary differences between mice and
zebrafish might have resulted in a deletion only in camta1a or in both
15

camta1a and b in zebrafish. This distinction cannot be made until the 5’end of
camta1b is located and aligned to the mouse genome, though. If evolutionary
divergence is the cause of this result, our plan to use homology analysis to
locate the promoter in the future may not work.
3. Alternative TSS –There is a possibility that has an alternative TSS in the heart.
This hypothesis could be tested by performing 5’RACE with RNA from
different tissues. Interestingly, the standard reaction performed using whole
embryo RNA showed a faint band of a different length than the small reaction,
which used only heart RNA (compare lane 3 to lanes 7 and 8 of figure 8).
We propose that future studies of camta1 focus on locating the 5’end of camta1b
through 5’RLM-RACE and continue analysis of the 5’ends of both genes to determine
their correct annotation and to identify their promoter regions. The alternative splicing
hypothesis can also be proven through an additional 5’RACE comparing RNA from
hearts, brains, and whole embryos. As camta1 studies continue in zebrafish, the 5’ends of
both genes will soon be fully elucidated, allowing for further studies to better understand
regulation of these genes and determine their proper annotation. As understanding of
camta1 increases, its putative role in heart development will also be revealed, leading to
breakthroughs in the treatment and prevention of CHDs.

16

References
Bakkers, J. 2011. “Zebrafish as a model to study cardiac development and human
cardiac disease.” Cardiovasc Res 91(2):279–288.
Edwards, Jonathon J. and Bruce D. Gelb. 2016. “Genetics of Congenital Heart
Disease.” Current Opinion in Cardiology 31(3): 235-241.
Frey, N., et al. 2000. Decoding calcium signals involved in cardiac growth and function.
Nat. Med. 6(11): 1221-1227.
Hanley, A., et al. 2016. Mutation of a common amino acid in NKX2.5 results in dilated
cardiomyopathy in two large families. BMC Medical Genetics, 17, 83.
http://doi.org/10.1186/s12881-016-0347-6
Hill, Jonathon T., Bradley Demarest, Bushra Gorsi, Megan Smith, and H. Joseph
Yost. 2017. “Heart morphogenesis gene regulatory networks revealed by temporal
expression analysis.” Development 144: 3487-3498.
Hoffman, Julien I.E. and Samuel Kaplan. 2002. “The Incidence of Congenital Heart
Disease.” Journal of the American College of Cardiology 39(12): 1890–1900.
Kim, Donghyuk et al. 2012. “Comparative Analysis of Regulatory Elements between
Escherichia coli and Klebsiella pneumoniae by Genome-Wide Transcription Start Site
Profiling.” PLoS Genetics 8(8): e1002867.
Kleinjan, Dirk A., et al. 2008. “Subfunctionalization of Duplicated Zebrafish pax6
Genes by cis-Regulatory Divergence.” PLoS Genetics 4(2): e29.
Li, J., et al. 2002. Calreticulin reveals a critical Ca2+ checkpoint in cardiac
myofibrillogenesis. The Journal of Cell Biology. 158(1): 103–113.
http://doi.org/10.1083/jcb.200204092
Liu, J., Whalley, H. J., and Knight, M. R. 2015. Combining modelling and
experimental approaches to explain how calcium signatures are decoded by calmodulin‐
binding transcription activators (CAMTAs) to produce specific gene expression
responses. The New Phytologist, 208(1), 174–187. http://doi.org/10.1111/nph.13428
Long, C., et al. 2014. “Ataxia and Purkinje cell degeneration in mice lacking the
CAMTA1 transcription factor.” Proc Nat Acad Sci 111(31): 11521–11526.
Nemer, Mona. 2007. “Genetic insights into normal and abnormal heart development.”
Cardiovascular Physiology 17(1):48-54.
Passier, R., et al. 2000. CaM kinase signaling induces cardiac hypertrophy and activates
the MEF2 transcription factor in vivo. Journal of Clinical Investigation. 105(10): 1395–
1406.

17

Porter, G. A., Makuck, R. F. and Rivkees, S. A. 2003. Intracellular calcium plays an
essential role in cardiac development. Dev. Dyn., 227: 280-290. doi:10.1002/dvdy.10307
Reamon-Buettner, S.M. and J. Borlak. 2010. NKX2–5: An Update on this
Hypermutable Homeodomain Protein and its Role in Human Congenital Heart Disease
(CHD). Human Mutation. 31( 11): 1185–1194. https://doiorg.erl.lib.byu.edu/10.1002/humu.21345
Schwartz, Robert J. and Michael D. Schneider. 2006. “CAMTA in Cardiac
Hypertrophy.” Cell 125(3): 427-429.
Song, Kunhua, et al. 2006. “The Transcriptional Coactivator CAMTA2 Stimulates
Cardiac Growth by Opposing Class II Histone Deacetylases.” Cell 125(3): 453–66.
Targoff, K. L., Schell, T., & Yelon, D. 2008. Nkx Genes Regulate Heart Tube Extension
and Exert Differential Effects on Ventricular and Atrial Cell Number. Developmental
Biology, 322(2), 314–321. http://doi.org/10.1016/j.ydbio.2008.07.037
Xu, J.H., et al. 2017. Prevalence and Spectrum of NKX2-5 Mutations Associated With
Sporadic Adult-Onset Dilated Cardiomyopathy. Int Heart J. 58(4):521-529. doi:
10.1536/ihj.16-440.
Xu, Y.J., et al. 2017. Prevalence and spectrum of NKX2.5 mutations in patients with
congenital atrial septal defect and atrioventricular block. Mol Med Rep. 15(4):2247-2254.
doi: 10.3892/mmr.2017.6249.

18

